Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1994 Sep;102(Suppl 3):215–219. doi: 10.1289/ehp.94102s3215

Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden.

J G Wetmur 1
PMCID: PMC1567421  PMID: 7843101

Abstract

delta-Aminolevulinate dehydratase (ALAD) is the second enzyme in the heme biosynthesis pathway. ALAD is a zinc metalloenzyme, and its inhibition by lead substitution for zinc is one of the most sensitive indicators of blood-lead accumulation, a measure of recent lead exposure. Stoichiometry calculations indicate that a significant portion of blood lead is stored in ALAD. Human ALAD exhibits a charge polymorphism, with about 20% of Caucasians expressing the rarer ALAD2 allele. Human ALAD1 and ALAD2 cDNAs and the 16-kb ALAD gene have been cloned and sequenced. A simple polymerase chain reaction test has been established and validated for determining ALAD genotypes. Two population studies have indicated that lead-exposed individuals with the ALAD2 allele have blood-lead levels about 10 micrograms/dl greater than similarly exposed individuals carrying only the ALAD1 allele. Ongoing work is directed toward determining the biochemistry underlying the allele-specific accumulation of blood lead, and toward determining the contribution of human ALAD genotype to lead accumulation in other tissues in transgenic mouse models and to final lead deposition in bone in both mouse and man.

Full text

PDF
215

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson P. M., Desnick R. J. Purification and properties of delta-aminolevulinate dehydrase from human erythrocytes. J Biol Chem. 1979 Aug 10;254(15):6924–6930. [PubMed] [Google Scholar]
  2. Astrin K. H., Bishop D. F., Wetmur J. G., Kaul B., Davidow B., Desnick R. J. delta-Aminolevulinic acid dehydratase isozymes and lead toxicity. Ann N Y Acad Sci. 1987;514:23–29. doi: 10.1111/j.1749-6632.1987.tb48757.x. [DOI] [PubMed] [Google Scholar]
  3. Audesirk G. Effects of lead exposure on the physiology of neurons. Prog Neurobiol. 1985;24(3):199–231. doi: 10.1016/0301-0082(85)90006-1. [DOI] [PubMed] [Google Scholar]
  4. Battistuzzi G., Petrucci R., Silvagni L., Urbani F. R., Caiola S. delta-Aminolevulinate dehydrase: a new genetic polymorphism in man. Ann Hum Genet. 1981 Jul;45(Pt 3):223–229. doi: 10.1111/j.1469-1809.1981.tb00333.x. [DOI] [PubMed] [Google Scholar]
  5. Bellinger D., Leviton A., Waternaux C., Needleman H., Rabinowitz M. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med. 1987 Apr 23;316(17):1037–1043. doi: 10.1056/NEJM198704233161701. [DOI] [PubMed] [Google Scholar]
  6. Benkmann H. G., Bogdanski P., Goedde H. W. Polymorphism of delta-aminolevulinic acid dehydratase in various populations. Hum Hered. 1983;33(1):62–64. doi: 10.1159/000153351. [DOI] [PubMed] [Google Scholar]
  7. Bergomi M., Borella P., Fantuzzi G., Vivoli G., Sturloni N., Cavazzuti G., Tampieri A., Tartoni P. L. Relationship between lead exposure indicators and neuropsychological performance in children. Dev Med Child Neurol. 1989 Apr;31(2):181–190. doi: 10.1111/j.1469-8749.1989.tb03977.x. [DOI] [PubMed] [Google Scholar]
  8. Bishop T. R., Cohen P. J., Boyer S. H., Noyes A. N., Frelin L. P. Isolation of a rat liver delta-aminolevulinate dehydrase (ALAD) cDNA clone: evidence for unequal ALAD gene dosage among inbred mouse strains. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5568–5572. doi: 10.1073/pnas.83.15.5568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bottomley S. S., Muller-Eberhard U. Pathophysiology of heme synthesis. Semin Hematol. 1988 Oct;25(4):282–302. [PubMed] [Google Scholar]
  10. Brennan M. J., Cantrill R. C. Delta-Aminolaevulinic acid and amino acid neurotransmitters. Mol Cell Biochem. 1981 Aug 11;38(Spec No)(Pt 1):49–58. doi: 10.1007/BF00235687. [DOI] [PubMed] [Google Scholar]
  11. Brennan M. J., Cantrill R. C. Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature. 1979 Aug 9;280(5722):514–515. doi: 10.1038/280514a0. [DOI] [PubMed] [Google Scholar]
  12. Chisolm J. J., Jr, Thomas D. J., Hamill T. G. Erythrocyte porphobilinogen synthase activity as an indicator of lead exposure in children. Clin Chem. 1985 Apr;31(4):601–605. [PubMed] [Google Scholar]
  13. Cutler M. G., McLaughlin M., McNeil E., Moore M. R. Effects of delta-aminolaevulinic acid on contractile activity in the isolated small intestine of the rabbit. Role of adrenergic receptors. Neuropharmacology. 1985 Oct;24(10):1005–1009. doi: 10.1016/0028-3908(85)90129-7. [DOI] [PubMed] [Google Scholar]
  14. Doss M., Laubenthal F., Stoeppler M. Lead poisoning in inherited delta-aminolevulinic acid dehydratase deficiency. Int Arch Occup Environ Health. 1984;54(1):55–63. doi: 10.1007/BF00378728. [DOI] [PubMed] [Google Scholar]
  15. Doss M., Müller W. A. Acute lead poisoning in inherited porphobilinogen synthase (delta-aminolevulinic acid dehydrase) deficiency. Blut. 1982 Aug;45(2):131–139. doi: 10.1007/BF00319941. [DOI] [PubMed] [Google Scholar]
  16. Doss M., von Tiepermann R., Schneider J., Schmid H. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochenschr. 1979 Oct 15;57(20):1123–1127. doi: 10.1007/BF01481493. [DOI] [PubMed] [Google Scholar]
  17. Giampietro P. F., Desnick R. J. Determination of delta-aminolevulinate dehydratase activity by a specific fluorometric coupled-enzyme assay. Anal Biochem. 1983 May;131(1):83–92. doi: 10.1016/0003-2697(83)90138-0. [DOI] [PubMed] [Google Scholar]
  18. Hassoun A., Verstraeten L., Mercelis R., Martin J. J. Biochemical diagnosis of an hereditary aminolaevulinate dehydratase deficiency in a 63-year-old man. J Clin Chem Clin Biochem. 1989 Oct;27(10):781–786. doi: 10.1515/cclm.1989.27.10.781. [DOI] [PubMed] [Google Scholar]
  19. Jaffe E. K., Bagla S., Michini P. A. Reevaluation of a sensitive indicator of early lead exposure. Measurement of porphobilinogen synthase in blood. Biol Trace Elem Res. 1991 Mar;28(3):223–231. doi: 10.1007/BF02990469. [DOI] [PubMed] [Google Scholar]
  20. Kaya A. H., Plewinska M., Wong D. M., Desnick R. J., Wetmur J. G. Human delta-aminolevulinate dehydratase (ALAD) gene: structure and alternative splicing of the erythroid and housekeeping mRNAs. Genomics. 1994 Jan 15;19(2):242–248. doi: 10.1006/geno.1994.1054. [DOI] [PubMed] [Google Scholar]
  21. Lippmann M. 1989 Alice Hamilton lecture. Lead and human health: background and recent findings. Environ Res. 1990 Feb;51(1):1–24. doi: 10.1016/s0013-9351(05)80179-3. [DOI] [PubMed] [Google Scholar]
  22. Marcus A. H., Schwartz J. Dose-response curves for erythrocyte protoporphyrin vs blood lead: effects of iron status. Environ Res. 1987 Dec;44(2):221–227. doi: 10.1016/s0013-9351(87)80230-x. [DOI] [PubMed] [Google Scholar]
  23. McMichael A. J., Baghurst P. A., Wigg N. R., Vimpani G. V., Robertson E. F., Roberts R. J. Port Pirie Cohort Study: environmental exposure to lead and children's abilities at the age of four years. N Engl J Med. 1988 Aug 25;319(8):468–475. doi: 10.1056/NEJM198808253190803. [DOI] [PubMed] [Google Scholar]
  24. Minnema D. J., Michaelson I. A. Differential effects of inorganic lead and delta-aminolevulinic acid in vitro on synaptosomal gamma-aminobutyric acid release. Toxicol Appl Pharmacol. 1986 Dec;86(3):437–447. doi: 10.1016/0041-008x(86)90371-6. [DOI] [PubMed] [Google Scholar]
  25. Müller W. E., Snyder S. H. delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. Ann Neurol. 1977 Oct;2(4):340–342. doi: 10.1002/ana.410020415. [DOI] [PubMed] [Google Scholar]
  26. Needleman H. L., Gunnoe C., Leviton A., Reed R., Peresie H., Maher C., Barrett P. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med. 1979 Mar 29;300(13):689–695. doi: 10.1056/NEJM197903293001301. [DOI] [PubMed] [Google Scholar]
  27. Needleman H. L., Schell A., Bellinger D., Leviton A., Allred E. N. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med. 1990 Jan 11;322(2):83–88. doi: 10.1056/NEJM199001113220203. [DOI] [PubMed] [Google Scholar]
  28. Petrucci R., Leonardi A., Battistuzzi G. The genetic polymorphism of delta-aminolevulinate dehydrase in Italy. Hum Genet. 1982;60(3):289–290. doi: 10.1007/BF00303023. [DOI] [PubMed] [Google Scholar]
  29. Plewinska M., Thunell S., Holmberg L., Wetmur J. G., Desnick R. J. delta-Aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote. Am J Hum Genet. 1991 Jul;49(1):167–174. [PMC free article] [PubMed] [Google Scholar]
  30. Rogan W. J., Reigart J. R., Gladen B. C. Association of amino levulinate dehydratase levels and ferrochelatase inhibition in childhood lead exposure. J Pediatr. 1986 Jul;109(1):60–64. doi: 10.1016/s0022-3476(86)80573-x. [DOI] [PubMed] [Google Scholar]
  31. Thunell S., Holmberg L., Lundgren J. Aminolaevulinate dehydratase porphyria in infancy. A clinical and biochemical study. J Clin Chem Clin Biochem. 1987 Jan;25(1):5–14. doi: 10.1515/cclm.1987.25.1.5. [DOI] [PubMed] [Google Scholar]
  32. Wetmur J. G., Bishop D. F., Cantelmo C., Desnick R. J. Human delta-aminolevulinate dehydratase: nucleotide sequence of a full-length cDNA clone. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7703–7707. doi: 10.1073/pnas.83.20.7703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wetmur J. G., Lehnert G., Desnick R. J. The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res. 1991 Dec;56(2):109–119. doi: 10.1016/s0013-9351(05)80001-5. [DOI] [PubMed] [Google Scholar]
  34. Winneke G., Brockhaus A., Ewers U., Krämer U., Neuf M. Results from the European multicenter study on lead neurotoxicity in children: implications for risk assessment. Neurotoxicol Teratol. 1990 Sep-Oct;12(5):553–559. doi: 10.1016/0892-0362(90)90022-5. [DOI] [PubMed] [Google Scholar]
  35. Winneke G., Krämer U., Brockhaus A., Ewers U., Kujanek G., Lechner H., Janke W. Neuropsychological studies in children with elevated tooth-lead concentrations. II. Extended study. Int Arch Occup Environ Health. 1983;51(3):231–252. doi: 10.1007/BF00377755. [DOI] [PubMed] [Google Scholar]
  36. Ziemsen B., Angerer J., Lehnert G., Benkmann H. G., Goedde H. W. Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers. Int Arch Occup Environ Health. 1986;58(3):245–247. doi: 10.1007/BF00432107. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES